PortfoliosLab logo
CL vs. CPRX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CL and CPRX is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.2

Performance

CL vs. CPRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Colgate-Palmolive Company (CL) and Catalyst Pharmaceuticals, Inc. (CPRX). The values are adjusted to include any dividend payments, if applicable.

220.00%240.00%260.00%280.00%300.00%320.00%340.00%360.00%NovemberDecember2025FebruaryMarchApril
345.29%
284.43%
CL
CPRX

Key characteristics

Sharpe Ratio

CL:

0.41

CPRX:

1.43

Sortino Ratio

CL:

0.69

CPRX:

2.29

Omega Ratio

CL:

1.09

CPRX:

1.26

Calmar Ratio

CL:

0.41

CPRX:

1.96

Martin Ratio

CL:

0.75

CPRX:

8.26

Ulcer Index

CL:

11.06%

CPRX:

7.17%

Daily Std Dev

CL:

20.07%

CPRX:

41.42%

Max Drawdown

CL:

-58.90%

CPRX:

-94.25%

Current Drawdown

CL:

-12.25%

CPRX:

-8.90%

Fundamentals

Market Cap

CL:

$76.17B

CPRX:

$2.86B

EPS

CL:

$3.51

CPRX:

$1.31

PE Ratio

CL:

26.76

CPRX:

17.90

PEG Ratio

CL:

2.02

CPRX:

0.00

PS Ratio

CL:

3.79

CPRX:

5.82

PB Ratio

CL:

359.29

CPRX:

3.89

Total Revenue (TTM)

CL:

$19.95B

CPRX:

$393.23M

Gross Profit (TTM)

CL:

$12.11B

CPRX:

$327.56M

EBITDA (TTM)

CL:

$4.73B

CPRX:

$177.46M

Returns By Period

In the year-to-date period, CL achieves a 4.47% return, which is significantly lower than CPRX's 12.36% return. Over the past 10 years, CL has underperformed CPRX with an annualized return of 5.66%, while CPRX has yielded a comparatively higher 21.69% annualized return.


CL

YTD

4.47%

1M

1.34%

6M

-0.67%

1Y

5.41%

5Y*

8.26%

10Y*

5.66%

CPRX

YTD

12.36%

1M

-5.60%

6M

9.27%

1Y

57.49%

5Y*

36.91%

10Y*

21.69%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CL vs. CPRX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CL
The Risk-Adjusted Performance Rank of CL is 6363
Overall Rank
The Sharpe Ratio Rank of CL is 6969
Sharpe Ratio Rank
The Sortino Ratio Rank of CL is 5858
Sortino Ratio Rank
The Omega Ratio Rank of CL is 5757
Omega Ratio Rank
The Calmar Ratio Rank of CL is 7070
Calmar Ratio Rank
The Martin Ratio Rank of CL is 6262
Martin Ratio Rank

CPRX
The Risk-Adjusted Performance Rank of CPRX is 9090
Overall Rank
The Sharpe Ratio Rank of CPRX is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of CPRX is 9090
Sortino Ratio Rank
The Omega Ratio Rank of CPRX is 8585
Omega Ratio Rank
The Calmar Ratio Rank of CPRX is 9393
Calmar Ratio Rank
The Martin Ratio Rank of CPRX is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CL vs. CPRX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Colgate-Palmolive Company (CL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CL, currently valued at 0.41, compared to the broader market-2.00-1.000.001.002.003.00
CL: 0.41
CPRX: 1.43
The chart of Sortino ratio for CL, currently valued at 0.69, compared to the broader market-6.00-4.00-2.000.002.004.00
CL: 0.69
CPRX: 2.29
The chart of Omega ratio for CL, currently valued at 1.09, compared to the broader market0.501.001.502.00
CL: 1.09
CPRX: 1.26
The chart of Calmar ratio for CL, currently valued at 0.41, compared to the broader market0.001.002.003.004.005.00
CL: 0.41
CPRX: 1.96
The chart of Martin ratio for CL, currently valued at 0.75, compared to the broader market-5.000.005.0010.0015.0020.00
CL: 0.75
CPRX: 8.26

The current CL Sharpe Ratio is 0.41, which is lower than the CPRX Sharpe Ratio of 1.43. The chart below compares the historical Sharpe Ratios of CL and CPRX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00NovemberDecember2025FebruaryMarchApril
0.41
1.43
CL
CPRX

Dividends

CL vs. CPRX - Dividend Comparison

CL's dividend yield for the trailing twelve months is around 2.15%, while CPRX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
CL
Colgate-Palmolive Company
2.15%2.18%2.40%2.36%2.10%2.05%2.48%2.79%2.11%2.37%2.25%2.05%
CPRX
Catalyst Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CL vs. CPRX - Drawdown Comparison

The maximum CL drawdown since its inception was -58.90%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CL and CPRX. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-12.25%
-8.90%
CL
CPRX

Volatility

CL vs. CPRX - Volatility Comparison

The current volatility for Colgate-Palmolive Company (CL) is 8.54%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 14.53%. This indicates that CL experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
8.54%
14.53%
CL
CPRX

Financials

CL vs. CPRX - Financials Comparison

This section allows you to compare key financial metrics between Colgate-Palmolive Company and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items